Study on the Treatment of Elderly Patients With Older and Newer Antiepileptic Drugs
Status:
Completed
Trial end date:
2011-08-01
Target enrollment:
Participant gender:
Summary
In this clinical trial patients with newly diagnosed focal epilepsy aged 60 years or older
receive three different antiepileptic drugs in a double-blind, randomized design over a
period of 58 weeks. All drugs are licensed for the treatment of epilepsy. The primary
endpoint of this study will be retention rate at 58-weeks, since it reflects both efficacy
and tolerability.